glp 1 and blood clots GLP-1 meds might reduce clot risk in diabetes patients Stop - A recent study

Retatrutide has not been approved for human use in the UK, and reconstitution and administration outside of a formal, ethics-approved clinical trial is not sanctioned by any UK regulatory body

Reduced appetite and food noise

[Crossref] [PubMed] Zhang X, Jiang N, Wang L, et al

Medications for Weight Loss: Zepbound (semaglutide injection): Approved for adults with obesity or overweight conditions and related health issues, Zepbound helps regulate appetite and promote satiety

Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder and as add-on to insulin for type 1 diabetes